How These Specialized Health Services Stocks are Faring? -- DaVita, HealthSouth, Acadia Healthcare, and MEDNAX

Wednesday, March 29, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 29, 2017 /PRNewswire/ --

Stock-Callers.com has issued research reports on the following equities:

DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), Acadia Healthcare Co. Inc. (NASDAQ: ACHC), and MEDNAX Inc. (NYSE: MD). These Specialized Health Services companies offer, on average, dividend yields that tend to be slightly above the market average.
Register now and get full and free access to our downloadable research reports on these stocks at:

http://stock-callers.com/registration

DaVita

On Tuesday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 1.14 million shares. The stock ended at $67.69, up 1.14% from the last trading session. The Company's shares have gained 3.82% over the previous three months and 5.44% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.06% and 1.05%, respectively. Furthermore, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have a Relative Strength Index (RSI) of 52.89.

On March 07th, 2017, DaVita announced that it has been recognized as one of FORTUNE Magazine World's Most Admired Companies in 2017. This is the 10th consecutive year and 11th year overall that the Company has appeared on the list. DaVita also ranked first in Quality of Products/Services in the health care medical facilities category. Access our complete research report on DVA for free at:

http://stock-callers.com/registration/?symbol=DVA

HealthSouth

Birmingham, Alabama headquartered HealthSouth Corp.'s stock finished yesterday's session 0.07% lower at $42.57. A total volume of 994,520 shares was traded, which was above their three months average volume of 993,140 shares. The Company's shares have gained 0.21% in the last one month, 1.10% over the previous three months, and 3.23% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 3.47% and 5.05%, respectively. Furthermore, shares of HealthSouth, which provides facility-based and home-based post-acute healthcare services in the US, have an RSI of 58.47.

On March 24th, 2017, HealthSouth announced that it will hold its annual meeting of stockholders at 11 a.m. CT on Thursday, May 04th, 2017, at its corporate headquarters at 3660 Grandview Parkway in Birmingham, Alabama. Stockholders and other interested parties may listen to a live audio webcast of the annual meeting, which will be available at http://investor.healthsouth.com. The complimentary research report on HLS can be downloaded at:

http://stock-callers.com/registration/?symbol=HLS

Acadia Healthcare

At the close of trading on Tuesday, shares in Franklin, Tennessee headquartered Acadia Healthcare Co. Inc. saw a drop of 1.02%, ending the day at $43.59. The stock recorded a trading volume of 1.57 million shares, which was above its three months average volume of 1.20 million shares. The Company's shares have advanced 25.69% in the previous three months and 31.69% since the start of this year. The stock is trading 6.32% above its 50-day moving average. Moreover, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have an RSI of 59.35. Register for free on Stock-Callers.com and get access to the latest PDF format report on ACHC at:

http://stock-callers.com/registration/?symbol=ACHC

MEDNAX

Sunrise, Florida headquartered MEDNAX Inc.'s shares ended the day 0.40% lower at $69.39 with a total trading volume of 460,316 shares. The stock has gained 2.41% over the previous three months and 4.10% on an YTD basis. The Company's shares are trading 2.38% above their 200-day moving average. Additionally, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 48.56.

On March 21st, 2017, research firm Robert W. Baird downgraded the Company's stock rating from 'Outperform' to 'Neutral', with a target price of $72 per share.

On March 23rd, 2017, MEDNAX announced the acquisition of Bruce E. Snyder, M.D., PLLC, a private pediatric ophthalmology practice based in Henderson, Nevada. With the acquisition, five physician group practices have become part of MEDNAX in 2017. Download your free research report on MD at:

http://stock-callers.com/registration/?symbol=MD

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook